2012, DNA, Small Molecule and Targeted Protein Degradation

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2012

DNA

Small Molecule

Targeted Protein Degradation

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

OCTOBER 16, 2023

A company within this ecosystem is STORM Therapeutics, a clinical stage biotechnology company creating novel small molecule therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases. The UK, and specifically Wales, has been hugely supportive of life sciences and building a highly collaborative network.

Drugs

Drugs Science Therapies Targeted Protein Degradation

Antibody-drug conjugates payloads: then, now and next

Drug Target Review

OCTOBER 4, 2023

2 In response, DNA-damaging agents that could target the entire cell cycle received renewed attention as ADC payloads. Groundbreaking strategies like proteolysis-targeting chimeric molecules (PROTACs) are also being explored. 4 But the horizon of ADCs is expanding even further, with the design of complex payloads.

Small Molecule

Small Molecule Drugs Immune Response Targeted Protein Degradation

Drug Discovery Digest

Where is the drug discovery expertise happening in the UK?

Antibody-drug conjugates payloads: then, now and next

Stay Connected